BR112021024634A2 - Método de tratamento ou prevenção de um distúrbio, doença ou condição aliviada pela estimulação ou modulação da expressão de colágeno - Google Patents

Método de tratamento ou prevenção de um distúrbio, doença ou condição aliviada pela estimulação ou modulação da expressão de colágeno

Info

Publication number
BR112021024634A2
BR112021024634A2 BR112021024634A BR112021024634A BR112021024634A2 BR 112021024634 A2 BR112021024634 A2 BR 112021024634A2 BR 112021024634 A BR112021024634 A BR 112021024634A BR 112021024634 A BR112021024634 A BR 112021024634A BR 112021024634 A2 BR112021024634 A2 BR 112021024634A2
Authority
BR
Brazil
Prior art keywords
stimulating
disorder
disease
treating
preventing
Prior art date
Application number
BR112021024634A
Other languages
English (en)
Inventor
J Bosques Carlos
Eva Genel
H Altman Gregory
Marius Costache
Original Assignee
Evolved By Nature Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Evolved By Nature Inc filed Critical Evolved By Nature Inc
Publication of BR112021024634A2 publication Critical patent/BR112021024634A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
    • A61K8/922—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/91—Injection

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Dermatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)

Abstract

método de tratamento ou prevenção de um distúrbio, doença ou condição aliviada pela estimulação ou modulação da expressão de colágeno. a invenção fornece composições de fibroína de seda para estimular a expressão de colágeno em um sujeito e métodos de uso das mesmas.
BR112021024634A 2019-06-06 2020-06-06 Método de tratamento ou prevenção de um distúrbio, doença ou condição aliviada pela estimulação ou modulação da expressão de colágeno BR112021024634A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201962858048P 2019-06-06 2019-06-06
PCT/US2020/036510 WO2020247887A1 (en) 2019-06-06 2020-06-06 Silk stimulated collagen production and methods of use thereof

Publications (1)

Publication Number Publication Date
BR112021024634A2 true BR112021024634A2 (pt) 2022-01-18

Family

ID=73652321

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112021024634A BR112021024634A2 (pt) 2019-06-06 2020-06-06 Método de tratamento ou prevenção de um distúrbio, doença ou condição aliviada pela estimulação ou modulação da expressão de colágeno

Country Status (7)

Country Link
US (1) US20220313590A1 (pt)
EP (1) EP3979873A4 (pt)
JP (1) JP2022534802A (pt)
AU (1) AU2020289479A1 (pt)
BR (1) BR112021024634A2 (pt)
CA (1) CA3140673A1 (pt)
WO (1) WO2020247887A1 (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022020332A1 (en) 2020-07-21 2022-01-27 Chembeau LLC Diester cosmetic formulations and uses thereof
TW202317214A (zh) 2021-06-23 2023-05-01 德商莫茲製藥有限兩合公司 以絲蛋白交聯多醣及所得材料之用途
IT202100021164A1 (it) * 2021-08-04 2023-02-04 Silk Medical S R L Composizione riempitiva per impianti intradermici
AU2022373663A1 (en) * 2021-10-18 2024-05-23 Evolved By Nature, Inc. Silk stimulated collagen and claudin-1 expression, and silk stimulated anti-inflammatory effects
WO2023215264A1 (en) * 2022-05-02 2023-11-09 Cocoon Biotech Inc. Methods for reducing impurities in silk fibroin preparations

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004062697A2 (en) * 2003-01-07 2004-07-29 Tufts University Silk fibroin materials and use thereof
US8986380B2 (en) * 2010-06-09 2015-03-24 Trustees Of Tufts College Multilayered silk scaffolds for meniscus tissue engineering
CN102091349B (zh) * 2011-01-27 2013-06-19 苏州大学 一种高强度生物支架材料及其制备方法
US10166177B2 (en) * 2013-09-30 2019-01-01 Silk Therapeutics, Inc. Silk protein fragment compositions and articles manufactured therefrom
KR101629204B1 (ko) * 2014-08-19 2016-06-10 전북대학교산학협력단 초박막 실크피브로인/콜라겐 복합이식체 및 이의 제조방법
MX2017013949A (es) * 2015-04-29 2018-11-09 Silk Therapeutics Inc Composiciones mectantes a base de seda y sus metodos.
WO2019005848A1 (en) * 2017-06-26 2019-01-03 Silk, Inc. HYALURONIC SILK ACID TISSUE FILLING AGENTS AND METHODS OF USE THEREOF
CN109529115A (zh) * 2019-01-03 2019-03-29 杜剑波 一种促进皮肤胶原再生的制剂及其制备方法
CN109758402A (zh) * 2019-03-29 2019-05-17 成都科奥生物工程有限公司 一种活能生命原液及其制备方法

Also Published As

Publication number Publication date
US20220313590A1 (en) 2022-10-06
WO2020247887A1 (en) 2020-12-10
EP3979873A4 (en) 2023-08-16
AU2020289479A1 (en) 2022-02-03
EP3979873A1 (en) 2022-04-13
CA3140673A1 (en) 2020-12-10
JP2022534802A (ja) 2022-08-03

Similar Documents

Publication Publication Date Title
BR112021024634A2 (pt) Método de tratamento ou prevenção de um distúrbio, doença ou condição aliviada pela estimulação ou modulação da expressão de colágeno
MX2022004874A (es) Compuestos de modulacion de glp-1r.
CY1125025T1 (el) 2-φορμυλ-3-υδροξυφαινυλοξυμεθυλ ενωσεις ικανες ρυθμισης αιμοσφαιρινης
EA201992497A1 (ru) МОДУЛЯТОРЫ K-Ras
MX2019007030A (es) Composiciones y metodos para el tratamiento del cancer.
BR112019006918A2 (pt) proteínas actriib variantes e usos das mesmas
MX2018001387A (es) Anticuerpo de dominio simple y proteinas derivadas del mismo contra ligando de muerte programada (pdl1).
EA201890329A1 (ru) СОЕДИНЕНИЯ В КАЧЕСТВЕ МОДУЛЯТОРОВ RORγ
EA202092000A1 (ru) Ингибиторы димеризации egfr и их использование
BR112019022908A2 (pt) Micropartícula de agregação sólida, sólido liofilizado ou reconstituível de micropartículas de agregação, método para tratamento de um distúrbio ocular, e, uso das micropartículas de agregação sólidas
CL2019002368A1 (es) Composiciones y métodos para el tratamiento de cáncer.
EA201892225A1 (ru) АНТИТЕЛА К ФАКТОРУ Bb КОМПЛЕМЕНТА И ИХ ПРИМЕНЕНИЕ
BR112019003731A2 (pt) aplicação de pridopidina para tratamento de distonias
BR112023021978A2 (pt) Compostos de carbóxi-benzimidazol moduladores de glp-1r
BR112023021561A2 (pt) Compostos de carbóxi-benzimidazol moduladores de glp-1r
BR112021026476A2 (pt) Aditivos para agentes corantes e método de uso dos mesmos
CO2019003865A2 (es) Proteína terapéutica
MX2016016407A (es) Composiciones biofotonicas termoestables y usos de las mismas.
BR112017020610A2 (pt) Compostos de anticorpo biespecífico anti-dkk-1- anti-rankl
BR112018072664A2 (pt) composições e métodos para tratamento de inflamação e infecção do olho
MX2020013100A (es) Metodos de uso de cd24 para la prevencion y tratamiento de enfermedad de injerto contra hospedero y mucositis.
PH12021550121A1 (en) Methods of treating hfpef employing dapagliflozin and compositions comprising the same
BR112022025845A2 (pt) Composição biocompatível, preenchimento de tecidos e método de tratamento ou prevenção de um distúrbio, doença ou condição
JOP20190164B1 (ar) تركيبات وطرق لعلاج داء فاربر
BR112018005602A2 (pt) composição para tratar dor